• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAYLIS MEDICAL COMPANY INC. VERSACROSS CONNECT LAAC ACCESS SOLUTION; DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION Back to Search Results
Lot Number VMFK211222
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problem Thrombosis/Thrombus (4440)
Event Date 03/21/2023
Event Type  Injury  
Event Description
It was reported that thrombosis occurred during procedure with watchman access system and versacross connect laac access system.A left atrial appendage (laa) closure procedure was being performed.A watchman fxd access system (was) was positioned toward the mitral annulus.The physician was inserting the pigtail catheter and as it came out of the was, discovered that the cheater was on the pigtail catheter.The pigtail catheter was removed, the cheater was taken off, and the pigtail catheter was re-inserted.The pigtail catheter was positioned into the laa and the was was advanced just past the laa ostium.It was then noticed that a clot or tissue was on the mitral valve annulus.The pigtail catheter was removed and the aspiration through the was attempted but unsuccessful.The procedure was aborted and patient was discharged the same day.It was further reported that the patient was administered heparin during the procedure and the initial activated clotting time (act) was taken during the trans-septal puncture and recorded at 299 seconds.The suspected thrombus was identified via transesophageal echocardiogram (tee) and was noted to be grounded to the mitral annulus and mobile.The suspected thrombus was not confirmed to have resolved during the procedure.In response to the event, the patient was switched from dual-antiplatelet therapy to eliquis and is expected to return 6 weeks later for a repeat tee.If the suspected thrombus has resolved, the watchman implant procedure will be reattempted.(b)(6) 2023: patient did not have any coagulopathies."cheater" is referring to the plastic tube that comes with pigtail catheters to straighten out the pigtail part so the physician can easily introduce it into the sheath.
 
Manufacturer Narrative
It was indicated that the device will not be returned for evaluation.If there is any further relevant information obtained, a supplemental medwatch will be filed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VERSACROSS CONNECT LAAC ACCESS SOLUTION
Type of Device
DILATOR, VESSEL, FOR PERCUTANEOUS CATHETERIZATION
Manufacturer (Section D)
BAYLIS MEDICAL COMPANY INC.
5959 trans-canada highway
montreal H4T 1 A1
CA  H4T 1A1
Manufacturer (Section G)
BAYLIS MEDICAL COMPANY INC.
5825 explorer drive
mississauga, on L4W 5 P6
CA   L4W 5P6
Manufacturer Contact
timothy degroot
4100 hamline avenue north
dc a330
saint paul, MN 55112
6515826168
MDR Report Key17686300
MDR Text Key322698047
Report Number2124215-2023-48113
Device Sequence Number1
Product Code DRE
UDI-Device Identifier00685447012597
UDI-Public00685447012597
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K220414
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial
Report Date 09/05/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Lot NumberVMFK211222
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 03/21/2023
Initial Date FDA Received09/05/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured08/04/2020
Is the Device Single Use? Yes
Type of Device Usage Unknown
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age73 YR
Patient SexFemale
-
-